Showing results (1-10 of 2,261) with videos related to
Sort By:
Pageof 227
Cancer Letters|January 3, 2016
Current progress in immunotherapy for pancreatic cancerKelly Foley, Victoria Kim, Elizabeth Jaffee, et al.Cell Adhesion & Migration|February 3, 2017
Hedgehog signaling stimulates Tenascin C to promote invasion of pancreatic ductal adenocarcinoma cells through Annexin A2Kelly Foley, Stephen Muth, Elizabeth Jaffee, et al.Journal of Visualized Experiments : Jove|October 7, 2014
A preclinical murine model of hepatic metastasesKevin C Soares, Kelly Foley, Kelly Olino, et al.Oncotarget|October 31, 2015
TGF-β blockade depletes T regulatory cells from metastatic pancreatic tumors in a vaccine dependent mannerKevin C Soares, Agnieszka A Rucki, Victoria Kim, et al.Journal for Immunotherapy of Cancer|January 16, 2020
NF-κB p50-deficient immature myeloid cell (p50-IMC) adoptive transfer slows the growth of murine prostate and pancreatic ductal carcinomaRahul Suresh, David J Barakat, Theresa Barberi, et al.Oncotarget|January 2, 2018
Stromal Annexin A2 expression is predictive of decreased survival in pancreatic cancerAdrian G Murphy, Kelly Foley, Agnieszka A Rucki, et al.Current Oncology Reports|May 19, 2019
Current Status of Immunotherapies for Treating Pancreatic CancerAnnie A Wu, Elizabeth Jaffee, Valerie LeeThe Lancet. Oncology|March 6, 2020
Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright futureEric S Christenson, Elizabeth Jaffee, Nilofer S AzadAdvances in Immunology|May 30, 2006
Mechanisms of immune evasion by tumorsCharles G Drake, Elizabeth Jaffee, Drew M PardollWorld Journal of Gastroenterology|June 25, 2016
Genomic change in hepatitis B virus associated with development of hepatocellular carcinomaDanbi Lee, Heather Lyu, Young-Hwa Chung, et al.Pageof 227